Correspondence 0001104659-23-069534 from Bellerophon Therapeutics, Inc. (BLPH) (CIK 0001600132)
Bellerophon Therapeutics, Inc. (BLPH) (CIK 0001600132)
Date: June 8, 2023 · CIK: 0001600132 · Accession: 0001104659-23-069534
AI Filing Summary & Sentiment
Letter
BELLEROPHON THERAPEUTICS, Inc.
20 Independence Boulevard, Suite 402
Warren, New Jersey 07059
June 8, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Jason Drory
Re: Bellerophon Therapeutics, Inc.
Registration Statement on Form S-3
Filed June 2, 2024
File No. 333- 272359 (the “Registration Statement”)
Acceleration Request
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Bellerophon Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Friday, June 9, 2023, at 4:01 p.m., Eastern Time, or as soon as thereafter practicable.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please contact Jeffrey Schultz of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6732 with any questions regarding this request.
Very truly yours,
BELLEROPHON THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
BELLEROPHON
THERAPEUTICS, Inc.
20 Independence Boulevard, Suite 402
Warren, New Jersey 07059
June 8, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Jason Drory
Re: Bellerophon Therapeutics, Inc.
Registration Statement on Form S-3
Filed June 2, 2024
File No. 333- 272359 (the “Registration
Statement”)
Acceleration Request
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C promulgated under the Securities
Act of 1933, as amended, Bellerophon Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the Securities
and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Friday, June 9, 2023, at 4:01
p.m., Eastern Time, or as soon as thereafter practicable.
The cooperation of the staff in meeting the timetable described above
is very much appreciated.
Please contact Jeffrey Schultz of Mintz, Levin, Cohn, Ferris, Glovsky
and Popeo, P.C., counsel to the Registrant, at (212) 692-6732 with any questions regarding this request.
Very truly yours,
BELLEROPHON THERAPEUTICS, INC.
/s/ Peter Fernandes
Peter Fernandes
Chief Financial Officer
cc: Mintz,
Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Jeffrey Schultz, Esq.